APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Digestive Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Digestive Drugs Market Analysis and Forecast 2026-2032

Report ID 173984610219 December 2025190 pages

Choose your research edition.

Industry ResearchDigestive Drugs Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Digestive Drugs Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Digestive Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Digestive Drugs Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Digestive Drugs Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Digestive Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Digestive Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Digestive Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Digestive Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Digestive Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Digestive Drugs include Eisai, Teva, Sanofi, Johnson & Johnson, Pfizer, Bayer, Jiangsu Aosaikang Pharma, AstraZeneca and Sumitomo, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Digestive Drugs, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Digestive Drugs, also provides the revenue of main regions and countries. Of the upcoming market potential for Digestive Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Digestive Drugs revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Digestive Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Digestive Drugs revenue, projected growth trends, production technology, application and end-user industry.

Digestive Drugs Segment by Company

Eisai

Teva

Sanofi

Johnson & Johnson

Pfizer

Bayer

Jiangsu Aosaikang Pharma

AstraZeneca

Sumitomo

Kyowa Kirin Pharmaceuticals

Hanmi Pharm

Cadila Pharmaceuticals

Digestive Drugs Segment by Type

OTC

Rx

Digestive Drugs Segment by Application

Hospital

Clinic

Digestive Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Digestive Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Digestive Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Digestive Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Digestive Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Digestive Drugs company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Digestive Drugs revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Digestive Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. OTC Major Player Table 3. Rx Major Player Table 4. Global Digestive Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Player Table 6. Clinic Major Player Table 7. Digestive Drugs Industry Trends Table 8. Digestive Drugs Industry Drivers Table 9. Digestive Drugs Industry Opportunities and Challenges Table 10. Digestive Drugs Industry Restraints Table 11. Global Digestive Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Digestive Drugs Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Digestive Drugs Market Share by Region (2021-2026) Table 14. Global Digestive Drugs Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Digestive Drugs Market Share by Region (2027-2032) Table 16. Global Digestive Drugs Revenue by Players (US$ Million) & (2021-2026) Table 17. Global Digestive Drugs Revenue Market Share by Players (2021-2026) Table 18. Global Digestive Drugs Key Players Ranking, 2024 VS 2025 VS 2026 Table 19. Global Digestive Drugs Key Players Headquarters & Area Served Table 20. Global Digestive Drugs Players, Product Type & Application Table 21. Global Digestive Drugs Players Establishment Date Table 22. Global Players Market Concentration Ratio (CR5 and HHI) Table 23. Global Digestive Drugs by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 24. Global Digestive Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Digestive Drugs Revenue by Type (2021-2026) & (US$ Million) Table 26. Global Digestive Drugs Revenue by Type (2027-2032) & (US$ Million) Table 27. Global Digestive Drugs Revenue Market Share by Type (2021-2026) Table 28. Global Digestive Drugs Revenue Market Share by Type (2027-2032) Table 29. Global Digestive Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Digestive Drugs Revenue by Application (2021-2026) & (US$ Million) Table 31. Global Digestive Drugs Revenue by Application (2027-2032) & (US$ Million) Table 32. Global Digestive Drugs Revenue Market Share by Application (2021-2026) Table 33. Global Digestive Drugs Revenue Market Share by Application (2027-2032) Table 34. Eisai Company Information Table 35. Eisai Business Overview Table 36. Eisai Digestive Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Eisai Digestive Drugs Product Portfolio Table 38. Eisai Recent Development Table 39. Teva Company Information Table 40. Teva Business Overview Table 41. Teva Digestive Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Teva Digestive Drugs Product Portfolio Table 43. Teva Recent Development Table 44. Sanofi Company Information Table 45. Sanofi Business Overview Table 46. Sanofi Digestive Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Sanofi Digestive Drugs Product Portfolio Table 48. Sanofi Recent Development Table 49. Johnson & Johnson Company Information Table 50. Johnson & Johnson Business Overview Table 51. Johnson & Johnson Digestive Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Johnson & Johnson Digestive Drugs Product Portfolio Table 53. Johnson & Johnson Recent Development Table 54. Pfizer Company Information Table 55. Pfizer Business Overview Table 56. Pfizer Digestive Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Pfizer Digestive Drugs Product Portfolio Table 58. Pfizer Recent Development Table 59. Bayer Company Information Table 60. Bayer Business Overview Table 61. Bayer Digestive Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Bayer Digestive Drugs Product Portfolio Table 63. Bayer Recent Development Table 64. Jiangsu Aosaikang Pharma Company Information Table 65. Jiangsu Aosaikang Pharma Business Overview Table 66. Jiangsu Aosaikang Pharma Digestive Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Jiangsu Aosaikang Pharma Digestive Drugs Product Portfolio Table 68. Jiangsu Aosaikang Pharma Recent Development Table 69. AstraZeneca Company Information Table 70. AstraZeneca Business Overview Table 71. AstraZeneca Digestive Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. AstraZeneca Digestive Drugs Product Portfolio Table 73. AstraZeneca Recent Development Table 74. Sumitomo Company Information Table 75. Sumitomo Business Overview Table 76. Sumitomo Digestive Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Sumitomo Digestive Drugs Product Portfolio Table 78. Sumitomo Recent Development Table 79. Kyowa Kirin Pharmaceuticals Company Information Table 80. Kyowa Kirin Pharmaceuticals Business Overview Table 81. Kyowa Kirin Pharmaceuticals Digestive Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Kyowa Kirin Pharmaceuticals Digestive Drugs Product Portfolio Table 83. Kyowa Kirin Pharmaceuticals Recent Development Table 84. Hanmi Pharm Company Information Table 85. Hanmi Pharm Business Overview Table 86. Hanmi Pharm Digestive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Hanmi Pharm Digestive Drugs Product Portfolio Table 88. Hanmi Pharm Recent Development Table 89. Cadila Pharmaceuticals Company Information Table 90. Cadila Pharmaceuticals Business Overview Table 91. Cadila Pharmaceuticals Digestive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Cadila Pharmaceuticals Digestive Drugs Product Portfolio Table 93. Cadila Pharmaceuticals Recent Development Table 94. North America Digestive Drugs Revenue by Type (2021-2026) & (US$ Million) Table 95. North America Digestive Drugs Revenue by Type (2027-2032) & (US$ Million) Table 96. North America Digestive Drugs Revenue by Application (2021-2026) & (US$ Million) Table 97. North America Digestive Drugs Revenue by Application (2027-2032) & (US$ Million) Table 98. North America Digestive Drugs Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 99. North America Digestive Drugs Revenue by Country (2021-2026) & (US$ Million) Table 100. North America Digestive Drugs Revenue by Country (US$ Million) & (2027-2032) Table 101. Europe Digestive Drugs Revenue by Type (2021-2026) & (US$ Million) Table 102. Europe Digestive Drugs Revenue by Type (2027-2032) & (US$ Million) Table 103. Europe Digestive Drugs Revenue by Application (2021-2026) & (US$ Million) Table 104. Europe Digestive Drugs Revenue by Application (2027-2032) & (US$ Million) Table 105. Europe Digestive Drugs Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 106. Europe Digestive Drugs Revenue by Country (2021-2026) & (US$ Million) Table 107. Europe Digestive Drugs Revenue by Country (US$ Million) & (2027-2032) Table 108. China Digestive Drugs Revenue by Type (2021-2026) & (US$ Million) Table 109. China Digestive Drugs Revenue by Type (2027-2032) & (US$ Million) Table 110. China Digestive Drugs Revenue by Application (2021-2026) & (US$ Million) Table 111. China Digestive Drugs Revenue by Application (2027-2032) & (US$ Million) Table 112. Asia Digestive Drugs Revenue by Type (2021-2026) & (US$ Million) Table 113. Asia Digestive Drugs Revenue by Type (2027-2032) & (US$ Million) Table 114. Asia Digestive Drugs Revenue by Application (2021-2026) & (US$ Million) Table 115. Asia Digestive Drugs Revenue by Application (2027-2032) & (US$ Million) Table 116. Asia Digestive Drugs Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 117. Asia Digestive Drugs Revenue by Region (US$ Million) & (2021-2026) Table 118. Asia Digestive Drugs Revenue by Region (US$ Million) & (2027-2032) Table 119. SAMEA Digestive Drugs Revenue by Type (2021-2026) & (US$ Million) Table 120. SAMEA Digestive Drugs Revenue by Type (2027-2032) & (US$ Million) Table 121. SAMEA Digestive Drugs Revenue by Application (2021-2026) & (US$ Million) Table 122. SAMEA Digestive Drugs Revenue by Application (2027-2032) & (US$ Million) Table 123. SAMEA Digestive Drugs Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 124. SAMEA Digestive Drugs Revenue by Country (2021-2026) & (US$ Million) Table 125. SAMEA Digestive Drugs Revenue by Country (US$ Million) & (2027-2032) Table 126. Research Programs/Design for This Report Table 127. Authors List of This Report Table 128. Secondary Sources Table 129. Primary Sources List of Figures Figure 1. Digestive Drugs Image Figure 2. Global Digestive Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Digestive Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. OTC Image Figure 5. Rx Image Figure 6. Global Digestive Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Digestive Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Global Digestive Drugs Market Size (US$ Million) & (2021-2032) Figure 11. Global Digestive Drugs Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Digestive Drugs Market Share by Region: 2021 VS 2025 VS 2032 Figure 13. Global Digestive Drugs Players Revenue Share Top 10 and Top 5 in 2025 Figure 14. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 15. Global Digestive Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Digestive Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Digestive Drugs Revenue Market Share by Type (2021-2032) Figure 18. Global Digestive Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Digestive Drugs Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 20. Global Digestive Drugs Revenue Market Share by Application (2021-2032) Figure 21. North America Digestive Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Digestive Drugs Revenue Share by Type (2021-2032) Figure 23. North America Digestive Drugs Revenue Share by Application (2021-2032) Figure 24. North America Digestive Drugs Revenue Share by Country (2021-2032) Figure 25. United States Digestive Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 26. Canada Digestive Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Mexico Digestive Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Europe Digestive Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Digestive Drugs Revenue Share by Type (2021-2032) Figure 30. Europe Digestive Drugs Revenue Share by Application (2021-2032) Figure 31. Europe Digestive Drugs Revenue Share by Country (2021-2032) Figure 32. Germany Digestive Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. France Digestive Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. U.K. Digestive Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Italy Digestive Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Spain Digestive Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Russia Digestive Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Netherlands Digestive Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Nordic Countries Digestive Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. China Digestive Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 41. China Digestive Drugs Revenue Share by Type (2021-2032) Figure 42. China Digestive Drugs Revenue Share by Application (2021-2032) Figure 43. Asia Digestive Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. Asia Digestive Drugs Revenue Share by Type (2021-2032) Figure 45. Asia Digestive Drugs Revenue Share by Application (2021-2032) Figure 46. Asia Digestive Drugs Revenue Share by Region (2021-2032) Figure 47. Japan Digestive Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. South Korea Digestive Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. India Digestive Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. Australia Digestive Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Taiwan Digestive Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Southeast Asia Digestive Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. SAMEA Digestive Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 54. SAMEA Digestive Drugs Revenue Share by Type (2021-2032) Figure 55. SAMEA Digestive Drugs Revenue Share by Application (2021-2032) Figure 56. SAMEA Digestive Drugs Revenue Share by Country (2021-2032) Figure 57. Brazil Digestive Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Argentina Digestive Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Chile Digestive Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Colombia Digestive Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Peru Digestive Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Saudi Arabia Digestive Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Israel Digestive Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. UAE Digestive Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Turkey Digestive Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Iran Digestive Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Egypt Digestive Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • OTC
  • Rx
Applications
  • Hospital
  • Clinic
Companies covered
  • Eisai
  • Teva
  • Sanofi
  • Johnson & Johnson
  • Pfizer
  • Bayer
  • Jiangsu Aosaikang Pharma
  • AstraZeneca
  • Sumitomo
  • Kyowa Kirin Pharmaceuticals
  • Hanmi Pharm
  • Cadila Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Digestive Drugs Market by Type
  3. 1.2.1 Global Digestive Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 OTC
  5. 1.2.3 Rx
  6. 1.3 Digestive Drugs Market by Application
  7. 1.3.1 Global Digestive Drugs Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Digestive Drugs Market Dynamics
  1. 2.1 Digestive Drugs Industry Trends
  2. 2.2 Digestive Drugs Industry Drivers
  3. 2.3 Digestive Drugs Industry Opportunities and Challenges
  4. 2.4 Digestive Drugs Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Digestive Drugs Market Perspective (2021-2032)
  2. 3.2 Global Digestive Drugs Growth Trends by Region
  3. 3.2.1 Global Digestive Drugs Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Digestive Drugs Market Size by Region (2021-2026)
  5. 3.2.3 Global Digestive Drugs Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Digestive Drugs Revenue by Players
  2. 4.1.1 Global Digestive Drugs Revenue by Players (2021-2026)
  3. 4.1.2 Global Digestive Drugs Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Digestive Drugs Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Digestive Drugs Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Digestive Drugs Key Players Headquarters & Area Served
  7. 4.4 Global Digestive Drugs Players, Product Type & Application
  8. 4.5 Global Digestive Drugs Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Digestive Drugs Market CR5 and HHI
  11. 4.6.3 2025 Digestive Drugs Tier 1, Tier 2, and Tier 3
5 Digestive Drugs Market Size by Type
  1. 5.1 Global Digestive Drugs Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Digestive Drugs Revenue by Type (2021-2032)
  3. 5.3 Global Digestive Drugs Revenue Market Share by Type (2021-2032)
6 Digestive Drugs Market Size by Application
  1. 6.1 Global Digestive Drugs Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Digestive Drugs Revenue by Application (2021-2032)
  3. 6.3 Global Digestive Drugs Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Eisai
  2. 7.1.1 Eisai Company Information
  3. 7.1.2 Eisai Business Overview
  4. 7.1.3 Eisai Digestive Drugs Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Eisai Digestive Drugs Product Portfolio
  6. 7.1.5 Eisai Recent Developments
  7. 7.2 Teva
  8. 7.2.1 Teva Company Information
  9. 7.2.2 Teva Business Overview
  10. 7.2.3 Teva Digestive Drugs Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Teva Digestive Drugs Product Portfolio
  12. 7.2.5 Teva Recent Developments
  13. 7.3 Sanofi
  14. 7.3.1 Sanofi Company Information
  15. 7.3.2 Sanofi Business Overview
  16. 7.3.3 Sanofi Digestive Drugs Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Sanofi Digestive Drugs Product Portfolio
  18. 7.3.5 Sanofi Recent Developments
  19. 7.4 Johnson & Johnson
  20. 7.4.1 Johnson & Johnson Company Information
  21. 7.4.2 Johnson & Johnson Business Overview
  22. 7.4.3 Johnson & Johnson Digestive Drugs Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Johnson & Johnson Digestive Drugs Product Portfolio
  24. 7.4.5 Johnson & Johnson Recent Developments
  25. 7.5 Pfizer
  26. 7.5.1 Pfizer Company Information
  27. 7.5.2 Pfizer Business Overview
  28. 7.5.3 Pfizer Digestive Drugs Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Pfizer Digestive Drugs Product Portfolio
  30. 7.5.5 Pfizer Recent Developments
  31. 7.6 Bayer
  32. 7.6.1 Bayer Company Information
  33. 7.6.2 Bayer Business Overview
  34. 7.6.3 Bayer Digestive Drugs Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Bayer Digestive Drugs Product Portfolio
  36. 7.6.5 Bayer Recent Developments
  37. 7.7 Jiangsu Aosaikang Pharma
  38. 7.7.1 Jiangsu Aosaikang Pharma Company Information
  39. 7.7.2 Jiangsu Aosaikang Pharma Business Overview
  40. 7.7.3 Jiangsu Aosaikang Pharma Digestive Drugs Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Jiangsu Aosaikang Pharma Digestive Drugs Product Portfolio
  42. 7.7.5 Jiangsu Aosaikang Pharma Recent Developments
  43. 7.8 AstraZeneca
  44. 7.8.1 AstraZeneca Company Information
  45. 7.8.2 AstraZeneca Business Overview
  46. 7.8.3 AstraZeneca Digestive Drugs Revenue and Gross Margin (2021-2026)
  47. 7.8.4 AstraZeneca Digestive Drugs Product Portfolio
  48. 7.8.5 AstraZeneca Recent Developments
  49. 7.9 Sumitomo
  50. 7.9.1 Sumitomo Company Information
  51. 7.9.2 Sumitomo Business Overview
  52. 7.9.3 Sumitomo Digestive Drugs Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Sumitomo Digestive Drugs Product Portfolio
  54. 7.9.5 Sumitomo Recent Developments
  55. 7.10 Kyowa Kirin Pharmaceuticals
  56. 7.10.1 Kyowa Kirin Pharmaceuticals Company Information
  57. 7.10.2 Kyowa Kirin Pharmaceuticals Business Overview
  58. 7.10.3 Kyowa Kirin Pharmaceuticals Digestive Drugs Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Kyowa Kirin Pharmaceuticals Digestive Drugs Product Portfolio
  60. 7.10.5 Kyowa Kirin Pharmaceuticals Recent Developments
  61. 7.11 Hanmi Pharm
  62. 7.11.1 Hanmi Pharm Company Information
  63. 7.11.2 Hanmi Pharm Business Overview
  64. 7.11.3 Hanmi Pharm Digestive Drugs Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Hanmi Pharm Digestive Drugs Product Portfolio
  66. 7.11.5 Hanmi Pharm Recent Developments
  67. 7.12 Cadila Pharmaceuticals
  68. 7.12.1 Cadila Pharmaceuticals Company Information
  69. 7.12.2 Cadila Pharmaceuticals Business Overview
  70. 7.12.3 Cadila Pharmaceuticals Digestive Drugs Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Cadila Pharmaceuticals Digestive Drugs Product Portfolio
  72. 7.12.5 Cadila Pharmaceuticals Recent Developments
8 North America
  1. 8.1 North America Digestive Drugs Revenue (2021-2032)
  2. 8.2 North America Digestive Drugs Revenue by Type (2021-2032)
  3. 8.2.1 North America Digestive Drugs Revenue by Type (2021-2026)
  4. 8.2.2 North America Digestive Drugs Revenue by Type (2027-2032)
  5. 8.3 North America Digestive Drugs Revenue Share by Type (2021-2032)
  6. 8.4 North America Digestive Drugs Revenue by Application (2021-2032)
  7. 8.4.1 North America Digestive Drugs Revenue by Application (2021-2026)
  8. 8.4.2 North America Digestive Drugs Revenue by Application (2027-2032)
  9. 8.5 North America Digestive Drugs Revenue Share by Application (2021-2032)
  10. 8.6 North America Digestive Drugs Revenue by Country
  11. 8.6.1 North America Digestive Drugs Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Digestive Drugs Revenue by Country (2021-2026)
  13. 8.6.3 North America Digestive Drugs Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Digestive Drugs Revenue (2021-2032)
  2. 9.2 Europe Digestive Drugs Revenue by Type (2021-2032)
  3. 9.2.1 Europe Digestive Drugs Revenue by Type (2021-2026)
  4. 9.2.2 Europe Digestive Drugs Revenue by Type (2027-2032)
  5. 9.3 Europe Digestive Drugs Revenue Share by Type (2021-2032)
  6. 9.4 Europe Digestive Drugs Revenue by Application (2021-2032)
  7. 9.4.1 Europe Digestive Drugs Revenue by Application (2021-2026)
  8. 9.4.2 Europe Digestive Drugs Revenue by Application (2027-2032)
  9. 9.5 Europe Digestive Drugs Revenue Share by Application (2021-2032)
  10. 9.6 Europe Digestive Drugs Revenue by Country
  11. 9.6.1 Europe Digestive Drugs Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Digestive Drugs Revenue by Country (2021-2026)
  13. 9.6.3 Europe Digestive Drugs Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Digestive Drugs Revenue (2021-2032)
  2. 10.2 China Digestive Drugs Revenue by Type (2021-2032)
  3. 10.2.1 China Digestive Drugs Revenue by Type (2021-2026)
  4. 10.2.2 China Digestive Drugs Revenue by Type (2027-2032)
  5. 10.3 China Digestive Drugs Revenue Share by Type (2021-2032)
  6. 10.4 China Digestive Drugs Revenue by Application (2021-2032)
  7. 10.4.1 China Digestive Drugs Revenue by Application (2021-2026)
  8. 10.4.2 China Digestive Drugs Revenue by Application (2027-2032)
  9. 10.5 China Digestive Drugs Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Digestive Drugs Revenue (2021-2032)
  2. 11.2 Asia Digestive Drugs Revenue by Type (2021-2032)
  3. 11.2.1 Asia Digestive Drugs Revenue by Type (2021-2026)
  4. 11.2.2 Asia Digestive Drugs Revenue by Type (2027-2032)
  5. 11.3 Asia Digestive Drugs Revenue Share by Type (2021-2032)
  6. 11.4 Asia Digestive Drugs Revenue by Application (2021-2032)
  7. 11.4.1 Asia Digestive Drugs Revenue by Application (2021-2026)
  8. 11.4.2 Asia Digestive Drugs Revenue by Application (2027-2032)
  9. 11.5 Asia Digestive Drugs Revenue Share by Application (2021-2032)
  10. 11.6 Asia Digestive Drugs Revenue by Country
  11. 11.6.1 Asia Digestive Drugs Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Digestive Drugs Revenue by Country (2021-2026)
  13. 11.6.3 Asia Digestive Drugs Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Digestive Drugs Revenue (2021-2032)
  2. 12.2 SAMEA Digestive Drugs Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Digestive Drugs Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Digestive Drugs Revenue by Type (2027-2032)
  5. 12.3 SAMEA Digestive Drugs Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Digestive Drugs Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Digestive Drugs Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Digestive Drugs Revenue by Application (2027-2032)
  9. 12.5 SAMEA Digestive Drugs Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Digestive Drugs Revenue by Country
  11. 12.6.1 SAMEA Digestive Drugs Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Digestive Drugs Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Digestive Drugs Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst